Portfolio update June 22/18 - another nice gain of 1% plus new stocks added
Slow and steady is the way to go IMHO. I would be totally happy with a 0.5% gain per week :)
Here is the chart for the portfolio
| Current Portfolio as of June 22, 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | Ticker | | Company | | Shares | | Price | | Value | | % Gain/loss | | Dividends | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | DRG/UN.TO | Dream Global REIT |
| 1000 |
| $14.53 |
| $14,530.00 |
| 13.96% |
| $500.03 |
|
|
|
| | ADW/A.TO |
| Andrew Peller Ltd. Class A |
| 2000 |
| $17.99 |
| $35,980.00 |
| 1.07% |
| $180.00 |
|
|
|
| | CF.TO |
| Canaccord Financial Inc. |
| 5000 |
| $7.25 |
| $36,250.00 |
| 5.84% |
| $50.00 |
|
|
|
| | TLT.V |
| Theralase Technologies Inc | 9250 |
| $0.380 |
| $3,515.00 |
| -6.17% |
| $0.00 |
|
|
|
| | CWX.TO |
| Canwel Holdings Inc |
| 1500 |
| $7.34 |
| $11,010.00 |
| 2.23% |
| $0.00 |
|
|
|
| | AI.TO |
| Atrium Mortgage Investment | 850 |
| $12.93 |
| $10,990.50 |
| -0.15% |
| $0.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Totals |
| $112,275.50 |
|
|
| $730.03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dividends added to available cash |
|
|
|
|
|
|
|
|
|
|
|
| %Gain/Loss based on Value only...no dividends |
|
|
|
| | ORDERS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| June 18/18: Limit buy of 1500 shares of Canwell Holdings Inc @ $7.18/share | | Done June 18/18 |
|
|
|
| June 18/18: Limit buy of 850 shares of Atrium Mortgage Investment @ $12.95/share Done June 18/18 | |
|
| Underexposed Canadian Fantasy Portfolio Value |
|
|
|
|
|
| | Initial: |
| $100,000.00 |
|
|
| | Cash : |
| $656.25 |
|
|
|
|
|
|
|
|
| | Date | | Value | | %Gain/Loss |
| | 15-Dec |
| $100,000.00 |
|
|
| | 22-Dec |
| $99,900.00 |
| -0.1% |
| | 29-Dec |
| $104,680.00 |
| 4.7% |
| | 5-Jan |
| $107,615.00 |
| 7.6% |
| | 12-Jan |
| $106,765.00 |
| 6.8% |
| | 19-Jan |
| $112,170.00 |
| 12.2% |
| | 26-Jan |
| $107,160.00 |
| 7.2% |
| | 2-Feb |
| $106,065.00 |
| 6.1% |
| | 9-Feb |
| $104,505.00 |
| 4.5% |
| | 8-Jun |
| $110,355.00 |
| 10.4% |
| | 15-Jun |
| $111,913.75 |
| 11.9% |
| | 22-Jun |
| $112,931.75 |
| 12.9% |
|
|
|
|
|
|
|
Conclusion
Canaccord continues to perform well and we had a nice bounce from Theralase.Theralase is really a long term hold. It will be entering Phase II of its trials soon and there is high hopes for this stock given its performance in their Phase I trial.
This should be a stable portfolio in content for a while. Check out Breakwater BRE.TO.... another choice has taken off as well but I was limited in funds in this portfolio... though I did make a purchase in my real portfoilio.
Good Trading
UE |
